<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01562366</url>
  </required_header>
  <id_info>
    <org_study_id>SM-2012-01</org_study_id>
    <nct_id>NCT01562366</nct_id>
  </id_info>
  <brief_title>Research Study to Compare the Addition of Topaz Micro Debridement to the Standard of Care Surgery</brief_title>
  <official_title>A Randomised, Controlled, Double-blind Clinical Investigation on the Efficacy and Safety of Radiofrequency Micro Debridement, Topaz, in Recalcitrant Greater Trochanteric Pain Syndrome (GTPS) vs. Standard of Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare the surgical use of Topaz with the Standard Of Care in the treatment of Greater
      Trochanteric Pain Syndrome (a type of hip pain). The hypothesis is that there is a difference
      between the two treatment groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Harris Hip Score</measure>
    <time_frame>6 months</time_frame>
    <description>This is a patient questionnaire used to evaluate hip function following surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Western Ontario and McMaster Universities Arthritis Index</measure>
    <time_frame>1 year</time_frame>
    <description>This is a patient questionnaire used to evaluate rheumatic symptoms, stiffness, pain and how it affects the ability to function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>1 year</time_frame>
    <description>This is a patient questionnaire designed to evaluate pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-12 Health Survey</measure>
    <time_frame>1 year</time_frame>
    <description>This is a patient questionnaire measuring health-related quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of surgery between two treatment groups</measure>
    <time_frame>1 day</time_frame>
    <description>The total length (time) of surgery will be compared between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultrasound findings</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Greater Trochanteric Pain Syndrome</condition>
  <condition>Hip Pain Chronic</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Topaz</intervention_name>
    <description>Radiofrequency micro debridement with Topaz will be used to treat the gluteal tendons following standard of care procedure</description>
    <arm_group_label>Group 1</arm_group_label>
    <other_name>Topaz AC-4045-01</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Iliotibial band release and trochanteric bursectomy</intervention_name>
    <description>Standard of Care: An iliotibial band release and trochanteric bursectomy will be performed.</description>
    <arm_group_label>Group 2</arm_group_label>
    <other_name>Standard of Care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female or male aged between 40-70 years old, females and males are eligible

          2. A history of &gt; 6 months of conservative care treatment for lateral hip pain, including
             but not limited to local anaesthetic and steroid injections into the trochanteric
             bursa

          3. Pre-operative MRI and ultrasound with evidence of GTPS within the previous 24 weeks

          4. Willing to comply with the protocol and follow-up visits

          5. Signed the Independent Ethics Committee (IEC) approved Informed Consent Form

        Exclusion Criteria:

          1. Previous surgery to the hip such as hip replacement, fracture neck of femur fixation,
             or repair of gluteal tendons

          2. Subjects with sero-positive or sero-negative arthropathy

          3. Long term steroid use &gt; 6 weeks

          4. Allergy to drugs to be used in the procedure

          5. Medical co-morbidities that preclude surgical intervention

          6. Inability to understand or respond to the study questionnaires

          7. Females who are pregnant, or pregnancy is suspected or planned within the clinical
             investigation timeframe

          8. Subjects who are simultaneously participating in another device or pharmaceutical
             investigation

        Intra-operative Exclusion:

          1. Abductor tears

          2. Severe tendinopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John O'Donnell, M.B., B.S.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Epworth Private Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Victoria</state>
        <zip>3121</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2012</study_first_posted>
  <last_update_submitted>May 23, 2017</last_update_submitted>
  <last_update_submitted_qc>May 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Iliotibial Band Release</keyword>
  <keyword>Trochanteric Bursectomy</keyword>
  <keyword>Micro debridement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

